-
1 Comment
Zhejiang Ausun Pharmaceutical Co., Ltd is currently in a long term downtrend where the price is trading 11.0% below its 200 day moving average.
From a valuation standpoint, the stock is 104.6% more expensive than other stocks from the Healthcare sector with a price to sales ratio of 19.7.
Zhejiang Ausun Pharmaceutical Co., Ltd's total revenue rose by 24.0% to $92M since the same quarter in the previous year.
Its net income has dropped by 29.4% to $14M since the same quarter in the previous year.
Finally, its free cash flow fell by 35.3% to $9M since the same quarter in the previous year.
Based on the above factors, Zhejiang Ausun Pharmaceutical Co., Ltd gets an overall score of 1/5.
| Sector | Healthcare |
|---|---|
| Industry | Biotechnology |
| Exchange | SHG |
| CurrencyCode | CNY |
| ISIN | CNE100002XK2 |
| PE Ratio | 57.71 |
|---|---|
| Beta | -0.18 |
| Market Cap | 7B |
| Target Price | 20.39 |
| Dividend Yield | 0.8% |
Zhejiang Ausun Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of pharmaceutical formulations, specialty active pharmaceutical ingredients (APIs), and pharmaceutical intermediates in China and internationally. The company offers products for liver diseases, respiratory system diseases, cardiovascular and cerebrovascular diseases, high-end fluorine products, prostaglandins, antibacterial agents, gout, anti-tumor treatments, and nervous system disorders. It also provides customized contract research, development, and manufacturing services. In addition, the company engages in technology research and development, commissioned technology development, technology transfer, consulting, and promotion services; wholesale of organic intermediates; medical research and experimental development; market research; conference services; organization of exhibitions and displays; import and export trade of pharmaceuticals, food, cosmetics, medical devices, goods and technology, and related instruments and equipment; drug clinical trials; retail of pharmaceuticals; technical consultation and exchange; health consultation; and research and development of biochemical products. Zhejiang Ausun Pharmaceutical Co., Ltd. was incorporated in 2010 and is headquartered in Taizhou, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 603229.SHG using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2026
